Lanke Neticonazole Hydrochloride Cream

1. Indications and Usage
Dermatophytosis: Treatment of superficial fungal infections of the skin, including tinea corporis, tinea cruris, tinea pedis, and tinea manuum.
Pityriasis Versicolor: Treatment of tinea versicolor.
Cutaneous Candidiasis: Treatment of superficial cutaneous candidiasis.
2. Dosage and Administration
Route of Administration: For topical use ONLY. Do not ingest or use in eyes, mouth, or mucous membranes.
Recommended Dosage: Apply a thin layer to the affected area and surrounding skin once daily. For severe infections, application twice daily may be considered.
Treatment Duration: Continue treatment for 2 to 4 weeks to ensure clinical and mycological cure. For tinea versicolor, a minimum of 2 to 4 weeks of treatment is generally recommended.
Critical Administration Instructions:
Application: Wash and dry the affected area thoroughly before application.
Discontinuation: Discontinue if severe irritation occurs.
3. Mechanism of Action
Ergosterol Synthesis Inhibition: Neticonazole inhibits the biosynthesis of ergosterol, a key component of fungal cell membranes.
Membrane Damage: At fully inhibitory and fungicidal high concentrations, it directly damages the fungal cell membrane. This alteration in lipid composition disrupts membrane integrity and function, leading to fungal cell death.
4. Safety and Warnings
Hypersensitivity: Contraindicated in patients with known hypersensitivity to neticonazole, other imidazole antifungals, or any excipients in the formulation.
Ocular Avoidance: Strictly avoid contact with eyes, conjunctiva, and mucous membranes.
Skin Integrity: Do not apply to broken skin, open lesions, or areas of acute inflammation where burning or severe irritation may occur.
Pregnancy and Lactation: Use during pregnancy or breastfeeding only if the potential benefit justifies the potential risk to the fetus or infant.
5. Adverse Reactions and Clinical Research
Most Common Adverse Reactions: The most frequently reported adverse reactions include dermatitis (0.59%), pruritus (0.44%), irritation (0.19%), and erythema (0.15%).
Local Reactions: Mild and transient local reactions such as burning sensation, stinging, redness, or dryness may occur in the initial days of treatment.
6. Drug Interactions
Systemic Interactions: Systemic absorption of topically applied neticonazole is negligible; therefore, significant systemic drug-drug interactions are unlikely.
Concurrent Topical Agents: Use of occlusive dressings may increase local absorption; patients should be monitored for increased local irritation.
7. Pharmaceutical Information
Chemical Composition: Active Ingredient: Neticonazole Hydrochloride.
Appearance: White or off-white cream.
Packaging: Aluminum tube packaging (e.g., 10 g containing 0.1 g neticonazole).
Storage: Store in a well-closed container at controlled room temperature; protect from light.